Market Place
Sourcing Support
Mangalam Drugs expanding anti-malaria APl portfolio with Pyronaridine
21 Aug 2024 //
INDIANPHARMAPOST
Amivas` Artesunate Amivas (artesunate) Receives Approval in Europe
23 Aug 2023 //
EMA
AMIVAS Ireland Receives Authorisation from MHRA to Market Artesunate Amivas
13 Jun 2022 //
PRNEWSWIRE
EU Commission Grants AMIVAS Ireland Ltd. Approval to Market artesunate
24 Nov 2021 //
ADNKRONOS
Enforcement Report - Week of October 13, 2021
13 Oct 2021 //
FDA
WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients
12 Aug 2021 //
REUTERS
A giant trial of COVID-19 treatments is restarting
06 Aug 2021 //
SCIENCEMAG
La Jolla Pharma Receives Orphan Designation for Malaria Treatment
23 Jul 2019 //
CONTRACT PHARMA
Cipla launches anti-malaria drug for young children
25 Jul 2017 //
ECONOMIC TIMES
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.